Europe
Norgine Submits Marketing Authorisation Application to EMA for Eflornithine in High-Risk Neuroblastoma
Norgine announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk ne...
January 07, 2025 | News
Chime Biologics and Mabgeek Achieve Major Milestone with PPQ Completion for MG-K10 Antibody
Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance Marks a key step forward for t...
January 06, 2025 | News
European Commission Approves Amivantamab Plus Lazertinib for First-Line Treatment of EGFR-Mutated NSCLC
Janssen-Cilag International NV, a Johnson & Johnson company,announced the European Commission (EC) approval for a Type II variation indication extensio...
January 03, 2025 | News
Sensorion Completes Enrollment for First Cohort in Audiogene Phase 1/2 Gene Therapy Trial
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to re...
January 01, 2025 | News
India’s Akums Secures $200 Million Deal to Supply Oral Liquid Formulations for European Markets
Akums Drugs & Pharmaceuticals, a leading Indian contract development and manufacturing organization (CDMO), announced a landmark $200 million agreement...
December 27, 2024 | News
Achilles Therapeutics Transfers TRACERx and MAP Data to AstraZeneca in $12M Deal
Proprietary data and samples from TRACERx and Achilles’ Material Acquisition Platform (MAP) will be transferred to AstraZeneca under the Transa...
December 25, 2024 | News
Daiichi Sankyo and AstraZeneca Withdraw EU Application for Datopotamab Deruxtecan in NSCLC
Daiichi Sankyo and AstraZeneca have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DX...
December 25, 2024 | News
BioPharma Europe: The Exclusive News Portal for the European Biopharma Industry
The European biopharmaceutical industry now has a dedicated platform for accessing the latest insights, trends, and developments with the launch of BioPhar...
December 24, 2024 | News
Sanofi and SK Bioscience Forge Expanded Alliance to Combat Pneumococcal Disease with Next-Gen Vaccines
Pneumococcal disease remains a major global health challenge despite the availability of current vaccines This 21-valent pneumococcal conjugate vaccine ...
December 23, 2024 | News
Merck Accelerates Next-Generation Drug Discovery with Acquisition of HUB Organoids
HUB internationally recognized pioneer in organoid development Acquisition expands Merck’s 2D and 3D cell culture portfolio Organoids part of fas...
December 19, 2024 | News
Lonza Opens State-of-the-Art R&D Facility in Slough, UK to Drive Biologics Innovation
Lonza, a global leader in biotechnology and pharmaceutical manufacturing, is proud to announce the opening of its new state-of-the-art research and develop...
December 19, 2024 | News
Sanofi and Teva Report Positive Phase 2b Results for Duvakitug in Ulcerative Colitis and Crohn’s Disease
Primary endpoints met in ulcerative colitis (UC) and Crohn’s disease (CD), the most common forms of inflammatory bowel disease (IBD) Primary endpo...
December 18, 2024 | News
Menarini Group Reports Positive Phase 3 Results for Obicetrapib in Reducing LDL-C Levels
– Both pivotal studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapie...
December 17, 2024 | News
CHMP Endorses Celltrion’s Biosimilars Eydenzelt Stoboclo Osenvelt and Avtozma for Expanded Access to Biologic Treatments
The Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions for Celltrion’s three biosimilar candidates – Eydenz...
December 16, 2024 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
